NCI Recognizes 12 Clinical Investigators with Leadership Awards ► NCI Cancer Bulletin for December 11, 2012 - National Cancer Institute

NCI Cancer Bulletin for December 11, 2012 - National Cancer Institute

NCI Recognizes 12 Clinical Investigators with Leadership Awards

NCI has announced the recipients of this year's Cancer Clinical Investigator Team Leadership Awards. These awards recognize 12 highly exceptional clinical investigators for their contributions to the advancement of clinical research through collaborative team science:

• Dr. Lyudmila Bazhenova, UC San Diego Moores Cancer Center
• Dr. Lisa Bomgaars, Dan L. Duncan Cancer Center
• Dr. Alberto Broniscer, St. Jude Children's Research Hospital
• Dr. Daniel DeAngelo, Dana-Farber Cancer Institute        
• Dr. Konstantin Dragnev, Dartmouth-Hitchcock Norris Cotton Cancer Center
• Dr. Shirish Gadgeel, Barbara Ann Karmanos Cancer Institute
• Dr. Shannon Puhalla, University of Pittsburgh Cancer Institute
• Dr. Bart Scott, Fred Hutchinson Cancer Research Center
• Dr. B. Douglas Smith, Sidney Kimmel Comprehensive Cancer Center
• Dr. Jonathan Strosberg, H. Lee Moffitt Cancer Center & Research Institute
• Dr. Antoinette Tan, Cancer Institute of New Jersey
• Dr. Jason Zell, Chao Family Comprehensive Cancer Center        

Designed for mid-level clinical investigators, these 2-year awards provide recognition and up to $50,000 in funding for those who lead cancer research programs and clinical trials at NCI-designated cancer centers. The funding is provided to the recipient's institution and is applied toward the investigator's salary, fringe benefits, and associated facilities and administrative costs. Recipients are expected to devote 10 to 15 percent of their time to the activities associated with the award.
The awardees are all actively engaged in NCI-funded collaborative clinical trials and collaborate freely across disciplines, institutions, and programs to advance the design and conduct of cancer clinical trials. The clinical researchers also serve as mentors and academic role models for trainees and junior faculty interested in clinical research and clinical trials.
This annual award opportunity, now in its fourth year, is the result of the recommendations of NCI's Clinical Trials Working Group (CTWG). The working group was established to advise the institute on methods to improve and enhance publicly funded cancer clinical trials.
Learn more about how NCI is restructuring the national cancer clinical trials enterprise online.
NCI Cancer Bulletin for December 11, 2012 - National Cancer Institute